Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Dec;80(12):1035–1036. doi: 10.1136/bjo.80.12.1035

Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.

J Isaacs 1, A Dick 1
PMCID: PMC505697  PMID: 9059264

Full text

PDF
1036

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cobbold S. P., Adams E., Marshall S. E., Davies J. D., Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev. 1996 Feb;149:5–33. doi: 10.1111/j.1600-065x.1996.tb00897.x. [DOI] [PubMed] [Google Scholar]
  2. Cobbold S. P., Martin G., Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol. 1990 Dec;20(12):2747–2755. doi: 10.1002/eji.1830201232. [DOI] [PubMed] [Google Scholar]
  3. Cobbold S. P., Qin S., Leong L. Y., Martin G., Waldmann H. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev. 1992 Oct;129:165–201. doi: 10.1111/j.1600-065x.1992.tb01423.x. [DOI] [PubMed] [Google Scholar]
  4. Dick A. D., McMenamin P. G., Körner H., Scallon B. J., Ghrayeb J., Forrester J. V., Sedgwick J. D. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol. 1996 May;26(5):1018–1025. doi: 10.1002/eji.1830260510. [DOI] [PubMed] [Google Scholar]
  5. Isaacs J. D., Hale G., Waldmann H., Dick A. D., Haynes R., Forrester J. V., Watson P., Meyer P. A. Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H. Br J Ophthalmol. 1995 Nov;79(11):1054–1055. doi: 10.1136/bjo.79.11.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lockwood C. M., Thiru S., Isaacs J. D., Hale G., Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet. 1993 Jun 26;341(8861):1620–1622. doi: 10.1016/0140-6736(93)90759-a. [DOI] [PubMed] [Google Scholar]
  7. Newman D. K., Isaacs J. D., Watson P. G., Meyer P. A., Hale G., Waldmann H. Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H. Eye (Lond) 1995;9(Pt 5):564–569. doi: 10.1038/eye.1995.140. [DOI] [PubMed] [Google Scholar]
  8. Qin S., Cobbold S. P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. "Infectious" transplantation tolerance. Science. 1993 Feb 12;259(5097):974–977. doi: 10.1126/science.8094901. [DOI] [PubMed] [Google Scholar]
  9. Suttorp-Schulten M. S., Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996 Sep;80(9):844–848. doi: 10.1136/bjo.80.9.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Towler H. M., Lightman S. L., Forrester J. V. Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study. J Autoimmun. 1992 Apr;5 (Suppl A):259–264. doi: 10.1016/0896-8411(92)90041-n. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES